Our Senior Associate, Girish recently conducted an insightful session on Trademark Enforcement and Infringement for Lawkari, as part of their online certificate course. During the session, he provided a comprehensive overview of the various types of infringements recognized under the Trade Marks Act, 1999 and elaborated on the legal recourse available to brands facing such…
Our Senior Associate, Girish Bhatia conducted an engaging session on topic “Intellectual Property and INTA Unreal Campaign” on Friday, 14th March 2025, at VELS School of Law, Chennai. The session witnessed an enthusiastic gathering of over 180 students, with 100 participants joining virtually via Google Meet and the rest attending in person through classrooms. The…
Background The case involves a patent dispute between Pfizer Inc. and its subsidiaries (FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., and Wyeth LLC) (Petitioners) against Softgel Healthcare Private Limited (Respondent), an Indian Company. The dispute centres around the alleged infringement of Pfizer’s “441 Patent” related to TAFAMIDIS 61 mg capsules, sold under the brand name…
Our Senior Associate, Girish Bhatia, is honoured to be a part of the Two-Day International Conference on Intellectual Property Rights (IPR) organized by IILM University, Greater Noida, on March 10-11, 2025. As an esteemed panelist, he is honored to chair a session on “Preventive Measures, Risk Management, and Policy Recommendations”, alongside distinguished experts in the…
C.A.(COMM.IPD-PAT) 4/2025, I.A. 3780/2025 & I.A. 3781/2025 Delhi High Court The appellants through this Appeal before the Delhi High Court sought to overturn a decision by the Assistant Controller of Patents and Designs refusing their patent application, titled “Innovative Change To Solve Any Dispute, Unexpected Business Loss, Closures, Financial Loss, Unexpected Accidents,”. The application was…
We were delighted to be part of the 14th Annual Pharma IPR India Conference in Mumbai, where discussions around biologics and the evolving landscape of the Indian pharmaceutical industry took center stage. Suvarna Pandey, Associate Partner from our team participated in the conference. India, often referred to as the “pharmacy of the world,” plays a…
In a significant ruling, the Bombay High Court has set aside the Trade Marks Registry’s refusal Order to register the device mark consisting of Prakriti Paint with cow head device logo under Class 2. The Court held that the Registrar of Trade Marks erred in applying Section 9(1)(b) of the Trade Marks Act, 1999, which…
RNA, Technology and IP Attorneys is proud to have been a part of an engaging session organized by the Centre for Innovation, Intellectual Property and Competition (CIIPC) – IPR Chair, NLU Delhi, under the aegis of IQAC. Our colleagues, Adv. Girish Bhatia and Adv. Sonu Kapoor, led an insightful discussion on “Enforcement of IP and…
Understanding the Process and Procedures What is a .in domain dispute? .in domain dispute occurs when two or more parties claim rights to the same .in domain name. These disputes can arise due to various reasons, including trademark infringement, cybersquatting, or bad faith registration. Who oversees the resolution of .in domain disputes? The National Internet…
Q1: How does the Indian legal system differentiate between games of chance and games of skill? The Indian courts have used the “dominant factor test” or “predominant test” to determine whether skill or chance plays a predominant part in determining the result of the game. Games based on skill are kept out of the purview…
